The Effect of Symbiotic Beverage Consumption on Lipid Profile
SYMBIONIC
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether the synbiotic beverage "Daygurt" can improve lipid profiles, blood sugar levels, blood pressure, and body weight in individuals diagnosed with dyslipidemia. The main questions it aims to answer are: Does "Daygurt" significantly reduce total cholesterol and LDL levels compared to nutrition counseling alone? Does "Daygurt" increase HDL levels and reduce triglycerides more effectively than nutrition counseling? Does "Daygurt" lead to greater improvements in fasting blood sugar, blood pressure, and body weight compared to nutrition counseling? The intervention group (receiving "Daygurt" plus nutrition counseling) will be compared to the comparison group (receiving nutrition counseling without "Daygurt") to see if "Daygurt" provides additional benefits beyond standard dietary advice. Participants will be divided into 2 groups: Intervention group: Consume "Daygurt" daily for 8 weeks. Comparison group: Receive nutrition counseling sessions focused on managing dyslipidemia but will not consume "Daygurt." Both groups will undergo health parameter measurements before and after the intervention, including: Total cholesterol, LDL, HDL, and triglyceride levels. Fasting blood sugar. Blood pressure. Body mass index (BMI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2025
CompletedFirst Submitted
Initial submission to the registry
March 5, 2025
CompletedFirst Posted
Study publicly available on registry
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedMarch 25, 2025
March 1, 2025
4 months
March 5, 2025
March 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lipid profile
Fasting Total blood cholesterol, LDL cholesterol, HDL cholesterol and triglyceride level measured before and after intervention phase
6 weeks (before and after intervention)
Study Arms (2)
Intervention Group
EXPERIMENTALConsuming 100 ml Symbiotic beverages every day for 6 weeks plus dietary advice to overcome dyslipidemia
Comparison group
ACTIVE COMPARATORReceiving standard dietary advice to overcome dyslipidemia, but without drinking symbiotic beverage
Interventions
Provision of 100 ml symbiotic beverages "daygurt" per day for 6 weeks, plus standard dietary advice for dyslipidemia
Participants get standard dietary advice for dyslipidemia
Eligibility Criteria
You may qualify if:
- Cholesterol total above 200 mg/dl, or LDL Cholesterol above 100, or BMI above 25 kg/m2
- Agree to study protocols
You may not qualify if:
- Has Allergic to dairy product
- Having any drug lowering cholesterol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Ministry Polytechnic of Padang
Padang, West Sumatra, 25146, Indonesia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Dr
Study Record Dates
First Submitted
March 5, 2025
First Posted
March 25, 2025
Study Start
February 27, 2025
Primary Completion
June 15, 2025
Study Completion
October 15, 2025
Last Updated
March 25, 2025
Record last verified: 2025-03